Sebastiaan P. Van Kessel
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease.
Journal: NPJ Parkinson's disease
Published: June 07, 2021
Gut bacterial deamination of residual levodopa medication for Parkinson's disease.
Journal: BMC biology
Published: April 14, 2020
Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: October 15, 2019
Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.
Journal: Frontiers in neurology
Published: April 16, 2019
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
Journal: Nature communications
Published: September 19, 2018
High-throughput CRISPRi phenotyping identifies new essential genes in Streptococcus pneumoniae.
Journal: Molecular systems biology
Published: May 12, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026